Ashish Sarraju

Oct 9, 2024 | jacc.org | Sneha Jain |Ashish Sarraju |Nigam H. Shah |Kevin A. Schulman

References1. "Estimated costs of pivotal trials for novel therapeutic agents approved by the US Food and Drug Administration, 2015-2016". JAMA Intern Med . 2018;178:11: 1451-1457. 2. "Participation of women in clinical trials supporting FDA approval of cardiovascular drugs". J Am Coll Cardiol . 2018;71:18: 1960-1969. 3. "Artificial intelligence in cardiovascular clinical trials". J Am Coll Cardiol . 2024;84:2051-2062. 4.

Sep 1, 2024 | jacc.org | Ashish Sarraju |David Ouyang

IntroductionDiagnostic pathways within cardiology carry immense potential to benefit from artificial intelligence (AI)-enabled technologies.1 AI can track beat-to-beat ejection fraction, identify cardiac amyloidosis, and automate error-prone tedious measurements from images.1,2 As AI research for cardiovascular diagnosis gathers unprecedented momentum, a key question prevails: what cardiovascular conditions, or “use cases,” are ideal for the application of AI-based decision support?

Jan 4, 2024 | nature.com | Ashish Sarraju |Steven Nissen

AbstractAtherosclerotic plaque results from a complex interplay between lipid deposition, inflammatory changes, cell migration and arterial wall injury. Over the past two decades, clinical trials utilizing invasive arterial imaging modalities, such as intravascular ultrasonography, have shown that reducing levels of atherogenic lipoproteins, mainly serum LDL-cholesterol (LDL-C), to very low levels can safely reduce overall atherosclerotic plaque burden and favourably modify plaque composition.

Jul 3, 2023 | pubmed.ncbi.nlm.nih.gov | Ashish Sarraju |Fátima Rodriguez |Luke J. Laffin

Skip to main page content Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day?

Jul 3, 2023 | jamanetwork.com | Ashish Sarraju |Fátima Rodriguez |Luke J. Laffin

Cardiovascular Disease Prevention Recommendations From an Online Chat-Based AI Model—Reply Appropriateness of Cardiovascular Disease Prevention Recommendations From Online Chat-Based AI Model Ashish Sarraju, MD; Dennis Bruemmer, MD, PhD; Erik Van Iterson, PhD; Leslie Cho, MD; Fatima Rodriguez, MD, MPH; Luke Laffin, MD Cardiovascular Disease Prevention Recommendations From an Online Chat-Based AI Model George A.